There are a number of potential PhD projects available for 2018/2019 cohort that are linked to particular industrial partners. Choosing a PhD project that has an industry partner offers many benefits to both the student and the industry partner. As a student you will be provided with an additional industrial co-supervisor as a contact point. You will spend around 20% of your time at industrial R&D departments. This model for the CDT provides the PhD student with access to training, facilities and expertise not available in an academic setting. In addition, industrial partners provide student placements and industry workshops to demonstrate to students the potential application of their innovation and to highlight career pathways.
Apply for an industry project within the CDT
Here are the current PhD projects with an industry partner that are available to apply for:
This is an industrial PhD project aimed at developing novel imaging techniques for contrast-enhanced liver imaging using the ultrasound contrast agent (UCA) SonazoidTM. UCAs are micrometer size bubbles (with the size range of 3-10 µm diameters) that consist of an inert gas core encapsulated by a stabilizing shell (protein, lipid or polymer).
Myeloma is a debilitating haematological cancer that would benefit from early diagnosis, accurate quantification of disease burden & response assessment. This project aims to integrate novel acquisition techniques and develop quantitative whole skeleton imaging metrics for bone marrow disease, focusing on myeloma.
Apoptosis is the most common form of programmed cell death and is a key mechanism in many pathological diseases. These include cancer, diabetes, neurodegenerative disorders and aging. Being able to fully understand this mechanism could lead to huge advances in detection, drug development and treatment. Currently there are very few non-invasive techniques capable of quantifying and assessing the process of apoptosis in humans. The discovery that mitochondria play an important role in the early stages of apoptosis has directed focus to targeting the mitochondria as a means of identifying disease. Changes in mitochondrial membrane potential (m) can be directly related to mitochondrial dysfunction, representing a biophysical process that could be targeted with imaging.